Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies.
hepatocellular carcinoma
nonalcoholic fatty liver disease
type 2 diabetes
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
06 Feb 2023
06 Feb 2023
Historique:
received:
16
12
2022
revised:
01
02
2023
accepted:
03
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
In recent years, the incidence of non-viral hepatocellular carcinoma (HCC) has increased dramatically, which is probably related to the increased prevalence of metabolic syndrome, together with obesity and type 2 diabetes mellitus (T2DM). Several epidemiological studies have established the association between T2DM and the incidence of HCC and have demonstrated the role of diabetes mellitus as an independent risk factor for the development of HCC. The pathophysiological mechanisms underlying the development of Non-alcoholic fatty liver disease (NAFLD) and its progression to Non-alcoholic steatohepatitis (NASH) and cirrhosis are various and involve pro-inflammatory agents, oxidative stress, apoptosis, adipokines, JNK-1 activation, increased IGF-1 activity, immunomodulation, and alteration of the gut microbiota. Moreover, these mechanisms are thought to play a significant role in the development of NAFLD-related hepatocellular carcinoma. Early diagnosis and the timely correction of risk factors are essential to prevent the onset of liver fibrosis and HCC. The purpose of this review is to summarize the current evidence on the association among obesity, NASH/NAFLD, T2DM, and HCC, with an emphasis on clinical impact. In addition, we will examine the main mechanisms underlying this complex relationship, and the promising strategies that have recently emerged for these diseases' treatments.
Identifiants
pubmed: 36831004
pii: biomedicines11020468
doi: 10.3390/biomedicines11020468
pmc: PMC9953066
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Hepatol Int. 2016 Jul;10(4):632-9
pubmed: 26558795
Clin Res Cardiol. 2021 Jul;110(7):921-937
pubmed: 32696080
Biomed Pharmacother. 2018 Oct;106:991-1002
pubmed: 30119271
JHEP Rep. 2021 Jan 19;3(2):100231
pubmed: 33748726
Clin Gastroenterol Hepatol. 2015 Apr;13(4):643-54.e1-9; quiz e39-40
pubmed: 24768810
Trends Endocrinol Metab. 2017 Apr;28(4):250-260
pubmed: 27986466
Curr Hypertens Rep. 2018 Feb 26;20(2):12
pubmed: 29480368
Curr Diab Rep. 2019 Nov 27;19(12):151
pubmed: 31776781
Lancet Oncol. 2019 Feb;20(2):282-296
pubmed: 30665869
Cancers (Basel). 2021 Dec 31;14(1):
pubmed: 35008356
Am J Gastroenterol. 2019 Dec;114(12):1870-1877
pubmed: 31688024
Expert Opin Investig Drugs. 2022 Apr;31(4):347-360
pubmed: 35072571
Front Endocrinol (Lausanne). 2021 Dec 23;12:808526
pubmed: 35002979
Clin Gastroenterol Hepatol. 2006 Mar;4(3):369-80
pubmed: 16527702
Aging Cell. 2021 Dec;20(12):e13512
pubmed: 34761505
Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):196-205
pubmed: 26907882
Clin Gastroenterol Hepatol. 2018 Apr;16(4):558-566.e2
pubmed: 29223443
Drug Discov Today Dis Mech. 2010;7(2):e135-e143
pubmed: 21274425
Biochimie. 2005 Jan;87(1):81-6
pubmed: 15733741
Cleve Clin J Med. 2017 Jul;84(7 Suppl 1):S15-S21
pubmed: 28708479
Curr Res Pharmacol Drug Discov. 2021 Sep 04;2:100051
pubmed: 34909677
JHEP Rep. 2022 Mar 26;4(6):100479
pubmed: 35469167
Lancet Oncol. 2009 Jan;10(1):25-34
pubmed: 19095497
J Clin Oncol. 2021 Sep 20;39(27):3002-3011
pubmed: 34185551
Cell Mol Gastroenterol Hepatol. 2018 Sep 11;7(1):115-134
pubmed: 30510994
Nat Rev Gastroenterol Hepatol. 2020 Feb;17(2):66
pubmed: 31919473
Fibrogenesis Tissue Repair. 2012 Jun 06;5(Suppl 1):S24
pubmed: 23259531
Saudi J Gastroenterol. 2022 Mar-Apr;28(2):92-100
pubmed: 34810377
Aliment Pharmacol Ther. 2018 Mar;47(5):645-656
pubmed: 29333665
J Hepatol. 2021 Oct;75(4):960-974
pubmed: 34256065
Oncotarget. 2018 Jan 6;9(11):9925-9939
pubmed: 29515780
Am J Physiol Gastrointest Liver Physiol. 2011 Mar;300(3):G433-41
pubmed: 21233280
J Gastroenterol. 2018 Mar;53(3):362-376
pubmed: 29247356
Lancet. 2019 Dec 14;394(10215):2184-2196
pubmed: 31813633
Scand J Gastroenterol. 2013 Jan;48(1):78-87
pubmed: 23137049
Transplant Proc. 2013 Apr;45(3):1273-5
pubmed: 23622676
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Hepatology. 2018 May;67(5):1754-1767
pubmed: 28833331
Biomedicines. 2021 Sep 28;9(10):
pubmed: 34680462
Nutr Metab Cardiovasc Dis. 2019 Jun;29(6):531-543
pubmed: 30952576
Int J Mol Sci. 2020 Nov 07;21(21):
pubmed: 33171747
Curr Opin Clin Nutr Metab Care. 2018 Jul;21(4):277-282
pubmed: 29697539
Am J Emerg Med. 2017 May;35(5):749-752
pubmed: 28131601
Am J Gastroenterol. 2001 Aug;96(8):2462-7
pubmed: 11513191
Drug Des Devel Ther. 2021 Sep 22;15:3997-4009
pubmed: 34588764
Biomedicines. 2020 Jan 07;8(1):
pubmed: 31936158
Int J Cancer. 2012 Apr 1;130(7):1639-48
pubmed: 21544812
Gastroenterology. 2020 May;158(7):1999-2014.e1
pubmed: 32044314
Free Radic Res. 2015;49(12):1405-18
pubmed: 26223319
Expert Opin Investig Drugs. 2018 Mar;27(3):301-311
pubmed: 29448843
Endocrinology. 2014 Sep;155(9):3288-301
pubmed: 24949659
J Hepatol. 2009 Feb;50(2):351-7
pubmed: 19070395
Hepatology. 2015 Dec;62(6):1723-30
pubmed: 26274335
Nutr Metab Cardiovasc Dis. 2019 Sep;29(9):923-930
pubmed: 31377186
Sci Rep. 2016 Jun 09;6:27849
pubmed: 27279075
Biochim Biophys Acta. 2015 Oct;1851(10):1353-9
pubmed: 26172853
Cancers (Basel). 2020 May 26;12(6):
pubmed: 32466400
World J Gastroenterol. 2019 Feb 7;25(5):521-538
pubmed: 30774269
N Engl J Med. 2006 Nov 30;355(22):2297-307
pubmed: 17135584
Gastroenterology. 2017 Oct;153(4):996-1005.e1
pubmed: 28642197
Gastroenterology. 1998 Apr;114(4):842-5
pubmed: 9547102
Hepatology. 2021 Feb;73(2):833-842
pubmed: 32780879
Am J Med. 1999 Nov;107(5):450-5
pubmed: 10569299
Liver Int. 2017 Aug;37(8):1193-1201
pubmed: 28111883
Biomedicines. 2021 Jun 17;9(6):
pubmed: 34204571
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):771-8
pubmed: 26013675
Diabetologia. 2012 Oct;55(10):2565-2582
pubmed: 22869320
J Biol Chem. 2008 Dec 19;283(51):35375-82
pubmed: 18952604
J Clin Oncol. 2023 Mar 1;41(7):1434-1443
pubmed: 36455168
J Clin Oncol. 2020 Jan 20;38(3):193-202
pubmed: 31790344
N Engl J Med. 2018 Jul 05;379(1):54-63
pubmed: 29972759
PLoS One. 2011;6(12):e27326
pubmed: 22205924
Nat Med. 2009 Nov;15(11):1307-11
pubmed: 19838201
Front Pharmacol. 2019 Aug 06;10:877
pubmed: 31447675
Liver Int. 2020 Sep;40(9):2252-2262
pubmed: 32638496
Hepatology. 2022 Dec;76(6):1880-1897
pubmed: 35239194
Front Cell Infect Microbiol. 2022 May 27;12:870785
pubmed: 35694542
Risk Manag Healthc Policy. 2021 Feb 09;14:491-501
pubmed: 33603515
Ann Transl Med. 2020 Mar;8(6):380
pubmed: 32355824
Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):527-539
pubmed: 28676707
Sci Rep. 2021 Aug 18;11(1):16727
pubmed: 34408183
World J Gastroenterol. 2014 Jun 21;20(23):7381-91
pubmed: 24966608
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
Expert Rev Clin Pharmacol. 2022 Oct;15(10):1199-1208
pubmed: 36193738
Nutrients. 2015 Jun 19;7(6):4995-5019
pubmed: 26102213
Pharmaceuticals (Basel). 2019 Oct 10;12(4):
pubmed: 31658729
J Cell Mol Med. 2018 Jun;22(6):2970-2980
pubmed: 29524296
Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E718-28
pubmed: 12783775
Antioxidants (Basel). 2021 Feb 10;10(2):
pubmed: 33578702
J Gastroenterol. 2013 Apr;48(4):434-41
pubmed: 23397118
J Clin Invest. 2022 Nov 1;132(21):
pubmed: 36317632
BMJ. 2010 Nov 04;341:c5702
pubmed: 21051774
JAMA. 2009 Jan 7;301(1):39-51
pubmed: 19066370
Gut. 2005 Apr;54(4):533-9
pubmed: 15753540
Mol Metab. 2020 Jul;37:100980
pubmed: 32305491
Curr Oncol. 2022 Aug 04;29(8):5489-5507
pubmed: 36005172
Pharmaceuticals (Basel). 2020 Sep 04;13(9):
pubmed: 32899806
Metabolites. 2021 Jan 27;11(2):
pubmed: 33513761
Diabetes Obes Metab. 2018 Mar;20(3):734-739
pubmed: 28950422
Chin Med J (Engl). 2020 Dec 14;134(1):8-19
pubmed: 33323806
J Hepatol. 2018 Oct;69(4):896-904
pubmed: 29886156
Expert Opin Pharmacother. 2015;16(18):2719-25
pubmed: 26513009
N Engl J Med. 2010 May 6;362(18):1675-85
pubmed: 20427778
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
JAMA Oncol. 2020 Nov 01;6(11):e204564
pubmed: 33001135
Diabetes Metab Res Rev. 2019 Jan;35(1):e3070
pubmed: 30156747
Metabolism. 2016 Aug;65(8):1151-60
pubmed: 26907206
Lancet. 2017 Jan 7;389(10064):56-66
pubmed: 27932229
Contemp Clin Trials. 2020 Feb;89:105922
pubmed: 31881392
Aliment Pharmacol Ther. 2018 Oct;48(7):696-703
pubmed: 30136293
Adv Hepatol. 2014 Nov 30;2014:
pubmed: 26436133
PLoS One. 2016 May 20;11(5):e0151829
pubmed: 27203081
Gastroenterology. 2014 Mar;146(3):726-35
pubmed: 24316260
Front Cell Dev Biol. 2021 Dec 14;9:783088
pubmed: 34970545
JAMA Oncol. 2019 Dec 1;5(12):1749-1768
pubmed: 31560378
Br J Cancer. 2022 Jul;127(2):185-192
pubmed: 35264787
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Biomedicines. 2021 Sep 29;9(10):
pubmed: 34680473
Int J Mol Sci. 2021 Feb 16;22(4):
pubmed: 33669204
Int J Mol Sci. 2021 May 30;22(11):
pubmed: 34070765
J Hepatol. 2007 Oct;47(4):571-9
pubmed: 17644211
Hypertension. 2008 Sep;52(3):573-80
pubmed: 18678790
Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):629-36
pubmed: 18174459
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):260
pubmed: 32235911
Endocr J. 2019 Dec 25;66(12):1039-1046
pubmed: 31631098
Free Radic Biol Med. 2014 Jul;72:247-56
pubmed: 24746618
Annu Rev Med. 2016;67:103-17
pubmed: 26473416
Nat Rev Drug Discov. 2019 Jan;18(1):13-14
pubmed: 30168534
Am J Gastroenterol. 2013 Jun;108(6):881-91; quiz 892
pubmed: 23381014
Hepatology. 2018 Feb;67(2):549-559
pubmed: 28892558
Int J Mol Sci. 2016 Mar 25;17(4):447
pubmed: 27023533
Ann Oncol. 2019 May 1;30(5):871-873
pubmed: 30715202
Diabetes Metab. 2019 Jan;45(1):83-85
pubmed: 28778564
World J Gastroenterol. 2004 Apr 1;10(7):1047-51
pubmed: 15052691
Adv Exp Med Biol. 2018;1061:95-110
pubmed: 29956209
Metabolites. 2022 Jul 01;12(7):
pubmed: 35888734
Springerplus. 2015 Jul 15;4:346
pubmed: 26191473
Acta Pharm Sin B. 2022 Feb;12(2):558-580
pubmed: 35256934
Front Endocrinol (Lausanne). 2020 Dec 09;11:607011
pubmed: 33362721
Hepatology. 2018 May;67(5):1797-1806
pubmed: 29152763
Diabetes. 2013 Nov;62(11):3887-900
pubmed: 24159000
Expert Rev Gastroenterol Hepatol. 2020 May;14(5):311-321
pubmed: 32241197
Liver Int. 2016 Dec;36(12):1783-1792
pubmed: 27232579
Lancet Oncol. 2015 Jul;16(7):859-70
pubmed: 26095784
Gut. 2016 Aug;65(8):1359-68
pubmed: 25873639
Tissue Eng Regen Med. 2017 Jan 17;14(1):15-30
pubmed: 30603458
Front Med (Lausanne). 2021 Jun 30;8:695792
pubmed: 34277669
J Clin Oncol. 2020 Dec 20;38(36):4317-4345
pubmed: 33197225
Curr Vasc Pharmacol. 2012 Mar;10(2):162-72
pubmed: 22239625
J Clin Exp Hepatol. 2020 Jul-Aug;10(4):296-303
pubmed: 32655232
Gastroenterology. 2013 Sep;145(3):574-82.e1
pubmed: 23727264
Hepatology. 2016 Jan;63(1):138-47
pubmed: 26171685
Cell Metab. 2018 Oct 2;28(4):588-604.e5
pubmed: 30017357
PLoS One. 2018 Sep 25;13(9):e0204336
pubmed: 30252871
Nutrition. 2015 Jul-Aug;31(7-8):923-30
pubmed: 26059365
J Clin Invest. 2005 May;115(5):1343-51
pubmed: 15864352
Diabetes Metab. 2003 Nov;29(5):478-85
pubmed: 14631324
World J Gastroenterol. 2017 Feb 28;23(8):1458-1468
pubmed: 28293093
BMC Cancer. 2022 Oct 21;22(1):1085
pubmed: 36271374
Nutr Metab Cardiovasc Dis. 2021 Jul 22;31(8):2345-2353
pubmed: 34053830
Clin Cancer Res. 2020 Sep 15;26(18):4795-4804
pubmed: 32636319
Hepatology. 2022 Jun;75(6):1420-1428
pubmed: 34779535
Hepatology. 2016 Mar;63(3):827-38
pubmed: 26599351
Am J Physiol Endocrinol Metab. 2005 Aug;289(2):E187-96
pubmed: 16014356
Pharmacol Res. 2011 Apr;63(4):259-65
pubmed: 21211565